Stay updated on Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.

Latest updates to the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%
- Check20 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.SummaryDifference0.1%
- Check27 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Lung cancer, expanding the page to cover genetic aspects of lung cancer. No deletions were reported.SummaryDifference0.2%
- Check34 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' element has been removed.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to include new drug information and facility details, while several previous entries related to locations and specific drug classifications have been removed.SummaryDifference4%
Stay in the know with updates to Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.